Clinical Trial Update: Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on fluorescence imaging of adalimumab-680LT in inflammatory bowel disease (Crohn's disease and ulcerative colitis) across Phase 1 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Adalimumab-680LT (adalimumab)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Crohn Disease, Ulcerative Colitis | Phase 1, Phase 2 | Status: UNKNOWN